Cancer research helmed by a Johns Hopkins radiation oncology professor is the first to receive backing from a fund backing work that might create startups.
{iframe}https://technical.ly/baltimore/2018/01/04/bluefield-innovations-thinks-jhu-cancer-research-become-new-baltimore-company/?utm_campaign=Baltimore%20Editorial%20Email&utm_source=hs_email&utm_medium=email&utm_content=59788772&_hsenc=p2ANqtz-8lK_TzsmR3HEtnsa-fx7CpDfP887B5H_xhsLgNCyFZDQ-V2wvMkAMBgTHcijmaTeEr8lf65IgLdjDFo5H65jyuR4l0og&_hsmi=59788772{/iframe}